- Tytuł:
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet 19 August 2023 402(10402):613-626
Czasopismo naukowe